The clinical role and cost-effectiveness of long-acting antiretroviral therapy - Wikidata - awgldk - TriplyDB

The clinical role and cost-effectiveness of long-acting antiretroviral therapy

The clinical role and cost-effectiveness of long-acting antiretroviral therapy

http://www.wikidata.org/entity/Q35197271

about

Implementation challenges for long-acting antivirals as treatment.The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.Survival benefits of antiretroviral therapy in Brazil: a model-based analysis.Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa High self-reported non-adherence to antiretroviral therapy amongst adolescents living with HIV in Malawi: barriers and associated factors.Long-Acting Antiretrovirals: Where Are We now?Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study.Projecting 10-yr, 20-yr and Lifetime Risks of Cardiovascular Disease in Persons Living with HIV in the US.Lung Cancer Mortality Associated With Smoking and Smoking Cessation Among People Living With HIV in the United States.The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States.Emerging reverse transcriptase inhibitors for HIV-1 infection.

P2860

Q30375397-877DE1B6-9FFD-4D64-8917-2B97C7878A8D Q36635714-4E4AE891-6C26-4886-A9A5-B644DBDA9461 Q36747289-92A00DC2-C0F0-4A26-96F3-747F656B1FA3 Q36801543-222F4F83-98CA-4785-ADAE-F93934606BC2 Q37639081-532D35E4-4602-4E93-8FAA-96E27B4DD4ED Q37737731-247CC19F-CC24-4F1B-B0BF-946523C9E19A Q38838779-F0DDB253-9046-4741-9A68-E6616C8BF2A0 Q38902077-44B18756-840C-4C32-800E-72E145A4B2A7 Q39213747-FB278217-14F1-40B4-8A43-F5D694B9B4DD Q40163303-146EB46E-7FF7-485E-86D6-85F8A4093005 Q41925024-1316834C-D022-4BF0-BC70-D74793927B87 Q47549535-A386AEE6-8687-4BA1-97AB-BA328D751CC9 Q53686168-BA7A4CEC-2995-42D4-A9B0-D25EC2F33CB7

P2860

The clinical role and cost-effectiveness of long-acting antiretroviral therapy

http://www.wikidata.org/entity/Q35197271

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

The clinical role and cost-effectiveness of long-acting antiretroviral therapy

@ast

The clinical role and cost-effectiveness of long-acting antiretroviral therapy

@en

type

label

The clinical role and cost-effectiveness of long-acting antiretroviral therapy

@ast

The clinical role and cost-effectiveness of long-acting antiretroviral therapy

@en

prefLabel

The clinical role and cost-effectiveness of long-acting antiretroviral therapy

@ast

The clinical role and cost-effectiveness of long-acting antiretroviral therapy

@en

P1433

Q35197271-2B76F3D3-22E3-48FF-8C1B-CB223F2C792C

P1476

Q35197271-A0CD5C37-8679-4EDE-B4A0-052170931F4A

P2093

Q35197271-36C795EB-71DB-4452-8736-16434CF0A8F5

Q35197271-59D5B766-1686-4B60-AB03-1951DDDD8FFA

P2860

Q35197271-210474AB-104F-4A02-8329-98FAEA9DEFD0

Q35197271-213E7C83-D608-4A8B-9AFA-AC6A320066E0

Q35197271-21495FE6-F240-4EB1-8C97-A9BDE8AE9B06

Q35197271-22EEEE2F-24F9-493D-B69F-914BA5684E9D

Q35197271-2C958DFF-C0A2-4228-8E4F-D91EA5314850

Q35197271-2E517581-FA91-4DC4-A2BF-021139FCD3F4

Q35197271-32755BBB-E941-45FF-9E1E-CA4748A9D5AD

Q35197271-36D205B9-2416-4E66-919A-D6259A70974E

Q35197271-36E8CA16-4A91-445D-8828-3793734A799C

Q35197271-39D0C6A0-43BF-4273-9CC8-1A728AEB27C2

P304

Q35197271-2A71F8A9-0976-4AF5-94D3-BDD131C32AC7

P31

Q35197271-468587ED-9642-48A3-A30C-EBA5CA122ACC

P356

Q35197271-3471B21B-CEEC-4584-985A-13A65CD458ED

P407

Q35197271-EAA10AAA-D748-4795-8246-52C27504E09E

P433

Q35197271-88C76328-8E78-45B2-B522-76E1B43FD71B

P478

Q35197271-F4EA449D-CC1C-43CF-9E7A-12D514B0F4A6

P50

Q35197271-54C7E761-A7DD-4768-8C53-FCBA7C212B44

Q35197271-608C031B-A58C-4DDF-AA2B-F3EAFBF0DE18

Q35197271-7955FE00-9F5E-4A9C-A49E-F95C298A1AC6

Q35197271-7AAD61F2-F462-4EEB-B6AF-73BB55D107C6

Q35197271-89940E36-46C1-4E28-A064-B9A9E283E0FA

Q35197271-9B6CC5D4-F261-418C-921F-FCAF6A6DC420

P577

Q35197271-AC437B45-B5E8-403A-A1C7-8BDC159B05FF

P698

Q35197271-A5A4C6DE-6DF8-412B-8686-57B9F69E4731

P921

Q35197271-A484E87C-CC13-4EE4-A3D3-B3DAC8A43D14

P932

Q35197271-8020224A-4036-48F3-8403-897BB9F44101

P356

P1433

Clinical Infectious Diseases

P1476

The clinical role and cost-effectiveness of long-acting antiretroviral therapy

@en

P2093

Bruce R Schackman

http://www.w3.org/2001/XMLSchema#string

Paul E Sax

http://www.w3.org/2001/XMLSchema#string

P2860

Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment.

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.

Late presentation for human immunodeficiency virus care in the United States and Canada.

Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation

Assessing agreement in the timing of treatment initiation determined by repeated measurements of novel versus gold standard technologies with application to the monitoring of CD4 counts in HIV-infected patients.

Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States

Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 study.

The survival benefits of AIDS treatment in the United States.

P304

1102-1110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIU1159

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

Milton Weinstein

Rochelle P. Walensky

A. David Paltiel

Kenneth A Freedberg

P577

2015-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25583979

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4366583

http://www.w3.org/2001/XMLSchema#string